Clinical Trial Update: Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical rapamycin combined with calcitriol for facial angiofibromas in tuberous sclerosis complex has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Angiofibroma
• Tuberous Sclerosis Complex

Drugs mentioned

• Calcitriol (topical) (calcitriol)
• Rapamycin (topical) (sirolimus)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Facial Angiofibroma | Phase 3 | Status: COMPLETED